Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma is a hematological malignancy associated with increased cardiovascular morbidity and mortality. Its therapies also result in adverse cardiac effects. Since multiple myeloma is associated with increased expression of arginase, an enzyme that consumes an amino acid arg...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterek, Aleksandra, Oknińska, Marta, Pilch, Zofia, Sosnowska, Anna, Ramji, Kavita, Mackiewicz, Urszula, Golab, Jakub, Nowis, Dominika, Mączewski, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093116/
https://www.ncbi.nlm.nih.gov/pubmed/37046852
http://dx.doi.org/10.3390/cancers15072191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093116/
https://www.ncbi.nlm.nih.gov/pubmed/37046852
http://dx.doi.org/10.3390/cancers15072191

Ejemplares similares